Nurhadi Pradana, Daryanto Besut, Dhani Fauzan K, Purnomo Athaya F, Kusworini Kusworini, Alfandy Tommy N
Department of Urology, Saiful Anwar General Hospital, Malang, Indonesia.
Department of Urology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Narra J. 2025 Aug;5(2):e2474. doi: 10.52225/narra.v5i2.2474. Epub 2025 May 9.
The role of coenzyme Q10 (CoQ10) as an antioxidant in the context of cryptorchidism is increasingly recognized due to its potential protective effects against oxidative stress, a key contributor to testicular dysfunction in this condition. The aim of this study was to evaluate the antioxidant activity of CoQ10 and its impact on sperm parameters as an adjuvant therapy in a cryptorchidism mouse model. A total of 36 male Sprague Dawley mice were divided into six groups: control (negative control), cryptorchidism (positive control), orchidopexy only, and orchidopexy treated with CoQ10 at 5, 10 and 20 mg/kg body weight (BW). After seven days of induction into the cryptorchidism model, the mice underwent orchidopexy, and CoQ10 was administered orally from day 1 to day 7 post-orchidopexy. At the end of the treatment period, all mice were euthanized, and the left testes were collected for immunohistochemical analysis of malondialdehyde (MDA) and superoxide dismutase (SOD), as well as histological examination and sperm parameter assessment. Testicular tissue damage was assessed using the Cosentino grade, while spermatogenesis was evaluated using the Johnsen scoring system. Additionally, sperm parameters were analyzed from the left testis. MDA expression in the cryptorchidism group was significantly lower than in all CoQ10-treated groups (<0.001). In contrast, SOD expression was significantly higher in the cryptorchidism group compared to the 10 mg/kg BW and 20 mg/kg BW CoQ10 groups (both had <0.001). Cosentino grade and Johnsen score showed no significant differences between the control group and the group treated with 20 mg/kg BW CoQ10 (=0.891 and =0.123, respectively). Furthermore, the 20 mg/kg BW CoQ10 group had significantly greater sperm concentration and motility compared to the cryptorchidism group (<0.001 for both). These findings demonstrated that CoQ10 had significant antioxidant activity as an adjuvant therapy in a cryptorchidism mouse model. CoQ10 supplementation could reduce oxidative stress markers, enhance antioxidant enzyme expression, and improve sperm parameters, supporting its potential to mitigate testicular damage associated with cryptorchidism.
由于辅酶Q10(CoQ10)对氧化应激具有潜在的保护作用,而氧化应激是隐睾症中导致睾丸功能障碍的关键因素,因此其作为抗氧化剂在隐睾症中的作用日益受到认可。本研究的目的是评估CoQ10的抗氧化活性及其作为辅助治疗对隐睾症小鼠模型精子参数的影响。总共36只雄性斯普拉格-道利小鼠被分为六组:对照组(阴性对照)、隐睾症组(阳性对照)、仅进行睾丸固定术组,以及分别用5、10和20毫克/千克体重(BW)的CoQ10治疗的睾丸固定术组。在诱导建立隐睾症模型7天后,小鼠接受睾丸固定术,并且在睾丸固定术后第1天至第7天口服CoQ10。在治疗期结束时,所有小鼠均被安乐死,并收集左侧睾丸用于丙二醛(MDA)和超氧化物歧化酶(SOD)的免疫组织化学分析,以及组织学检查和精子参数评估。使用科森蒂诺分级评估睾丸组织损伤,同时使用约翰森评分系统评估精子发生情况。此外,对左侧睾丸的精子参数进行分析。隐睾症组中的MDA表达明显低于所有CoQ10治疗组(<0.001)。相反,与10毫克/千克体重和20毫克/千克体重的CoQ10组相比,隐睾症组中的SOD表达明显更高(两者均<0.001)。科森蒂诺分级和约翰森评分在对照组和用20毫克/千克体重CoQ10治疗的组之间没有显示出显著差异(分别为=0.891和=0.123)。此外,与隐睾症组相比,20毫克/千克体重CoQ10组的精子浓度和活力明显更高(两者均<0.001)。这些发现表明,在隐睾症小鼠模型中,CoQ10作为辅助治疗具有显著的抗氧化活性。补充CoQ10可以降低氧化应激标志物,增强抗氧化酶表达,并改善精子参数,这支持了其减轻与隐睾症相关的睾丸损伤的潜力。